Broadfin Capital LLC 13D/13G Filings for La Jolla Pharmaceutical Company (LJPC)

Broadfin Capital LLC 13D and 13G filings for La Jolla Pharmaceutical Company:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-01-04
11:15 am
Sale
2021-01-0413GLa Jolla Pharmaceutical Company
LJPC
Broadfin Capital LLC0
0.000%
-2,688,068decrease
(Position Closed)
Filing
2020-02-13
5:24 pm
Purchase
2019-12-3113GLa Jolla Pharmaceutical Company
LJPC
Broadfin Capital LLC2,688,068
9.900%
740,527increase
(+38.02%)
Filing